Moody’s assigns ‘A2’ rating to University of Maryland Medical System’s bonds

Moody’s Investors Service assigned an “A2” rating to Baltimore-based University of Maryland Medical System’s proposed $159.6 million of series 2017B bonds and $122.6 million of series 2017C bonds.

Advertisement

The rating assignment is based on a number of factors, including UMMS’ solid market share and strong position as the clinical training venue for Baltimore-based University of Maryland School of Medicine.

The outlook is stable, reflecting Moody’s Investors Service’s expectation that UMMS will continue to generate stable margins.

More articles on healthcare finance:
ACA repeal would trigger $166B loss for hospitals by 2026 — 3 things to know from AHA, FAH
6 experts share healthcare RCM predictions for 2017
Fitch issues stable outlook for US healthcare

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.